These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 33147451)
1. HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon. Miner JJ; Platt DJ; Ghaznavi CM; Chandra P; Santeford A; Menos AM; Dong Z; Wang ER; Qian W; Karozichian ES; Philips JA; Apte RS Cell Rep; 2020 Nov; 33(5):108339. PubMed ID: 33147451 [TBL] [Abstract][Full Text] [Related]
2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094 [TBL] [Abstract][Full Text] [Related]
3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
4. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Stanifer ML; Kee C; Cortese M; Zumaran CM; Triana S; Mukenhirn M; Kraeusslich HG; Alexandrov T; Bartenschlager R; Boulant S Cell Rep; 2020 Jul; 32(1):107863. PubMed ID: 32610043 [TBL] [Abstract][Full Text] [Related]
5. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Park A; Iwasaki A Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of SARS-CoV-2 by type I and type III interferons. Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093 [TBL] [Abstract][Full Text] [Related]
7. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation. Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187 [TBL] [Abstract][Full Text] [Related]
8. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19. Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans. Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F mBio; 2020 Oct; 11(5):. PubMed ID: 33067384 [TBL] [Abstract][Full Text] [Related]
10. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? Pique-Regi R; Romero R; Tarca AL; Luca F; Xu Y; Alazizi A; Leng Y; Hsu CD; Gomez-Lopez N Elife; 2020 Jul; 9():. PubMed ID: 32662421 [TBL] [Abstract][Full Text] [Related]
11. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019. O'Brien TR; Thomas DL; Jackson SS; Prokunina-Olsson L; Donnelly RP; Hartmann R Clin Infect Dis; 2020 Sep; 71(6):1410-1412. PubMed ID: 32301957 [No Abstract] [Full Text] [Related]
18. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571 [TBL] [Abstract][Full Text] [Related]
19. Zika Virus and Host Interactions: From the Bench to the Bedside and Beyond. Limonta D; Hobman TC Cells; 2020 Nov; 9(11):. PubMed ID: 33198165 [TBL] [Abstract][Full Text] [Related]
20. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Broggi A; Ghosh S; Sposito B; Spreafico R; Balzarini F; Lo Cascio A; Clementi N; De Santis M; Mancini N; Granucci F; Zanoni I Science; 2020 Aug; 369(6504):706-712. PubMed ID: 32527925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]